4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0000950170-25-013878
General Counsel sold 899 shares at $3.78 ($3,398)
- General Counsel acquired 2,687 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DENYES NANCY General Counsel | 2025-02-03 | Option exercise | +2,687 | 27,454 | D | ||
| DENYES NANCY General Counsel | 2025-02-04 | Sale | −899 | $3.78 | $3,398 | 26,555 | D |
| Derivatives | |||||||
| DENYES NANCY General Counsel | 2025-02-03 | Option exercise · Restricted Stock Unit | −2,687 | 2,687 | D | ||
| Open-market sales · 899 sh · avg $3.78 · $3,398 | |||||||
Loading xslF345X05/ownership.xml…